Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 10/21/2025CSPC's JSKN003 Granted Breakthru Therapy Designation in China
  • 10/21/2025Kelun-Biotech’s Sacituzumab Tirumotecan Shows Strong Phase 3 Results
  • 10/21/2025Riltide Completes Seed Financing to Advance AI-Driven Autoimmune Thera...
  • 10/21/2025Sunnovo Invests in Byterna to Advance Circular mRNA
  • 10/21/2025RemeGen's Disitamab Vedotin Plus Toripalimab Delivers Breakthru First-...
  • 10/21/2025Merck KGaA and Abbisko Report Strong Phase 3 Results for Pimicotinib a...
  • 10/20/2025Kelun Gains China Approval for First Homegrown HER2 Breast Cancer ADC
  • 10/20/2025China Accelerates Nationwide Rollout of Real-Time BMI Fund Settlement
  • 10/20/2025CDE Seeks Feedbacks on Draft Technical and Submission Requirements for...
  • 10/20/2025CDE Solicits Comments on the Reference Formulations for Chemical Gener...
  • 10/20/2025CDE Seeks Comments on Implementation Recommendations and Chinese Tran...
  • 10/20/2025Sanofi Launches €1B Insulin API Manufacturing Project in Beijing
  • 10/20/2025Akeso Reports Strong China Data for Ivonescimab in Lung Cancer
  • 10/17/2025Recent Executive Moves
  • 10/17/2025LEO Pharma's Anzupgo Cream NDA Accepted in China
  • 10/17/2025Gilead's Kite Strikes Up to $1.64B In Vivo CAR-T Deal with China's Pre...
  • 10/17/2025RemeGen's Telitacicept Demonstrates Strong Phase 3 Efficacy in Lupus, ...
  • 10/17/2025Dianthus Secures Exclusive Global Rights to DNTH212 from China's Leads...
  • 10/17/2025Roche Expands Oncology Pipeline Thru Global Licensing Deal with Hansoh...
  • 10/17/2025I-Mab to Rebrand as NovaBridge Biosciences and Pursue Hong Kong IPO
  • 10/16/2025NHC Holds High-Level Meetings with Abbott and Roche to Advance Healthc...
  • 10/16/2025China NMPA Cancels 80 Drug Registration Certificates, Including Lorata...
  • 10/16/2025Belite Bio Secures Priority Review from China's NMPA for Tinlarebant
  • 10/16/2025Kailera Launches with $600M Series B to Advance GLP-1 Portfolio Acqui...
  • 10/16/2025Xuanzhu Bio Soars on Hong Kong Debut After Highly Oversubscribed IPO
  • 10/16/2025Qilu Presents Promising Phase I Data for AR PROTAC Degrader QLH12016
  • 10/15/2025Sino Biopharma's TQB2102 Receives Breakthru Therapeutic Designation in...
  • 10/15/2025Pfizer CEO Calls for Greater U.S.–China Collaboration in Biopharma In...
  • 10/14/2025GSK's Shingrix Wins Chinese Approval for Expanded Use
  • 10/14/2025Biokin and SystImmune Present Promising Early Data for EGFR×HER3 Bisp...
  • Page:2/58 Total number of articles:1739: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group